Skip to main content
Clinical Trials/NCT03929146
NCT03929146
Completed
Phase 4

Randomized Trial Comparing Interscalene Nerve Block to Liposomal Bupivacaine For Pain Management Following Reverse Total Shoulder Arthroplasty (RTSA)

University of Cincinnati1 site in 1 country76 target enrollmentFebruary 5, 2019

Overview

Phase
Phase 4
Intervention
Exparel
Conditions
Pain, Postoperative
Sponsor
University of Cincinnati
Enrollment
76
Locations
1
Primary Endpoint
Patient Satisfaction: Rating
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The aim of this study is to compare two different pain management interventions in patients undergoing reverse total shoulder arthroplasty. The two interventions are 1) pre-operative interscalene nerve block and 2) intraoperative injection of liposomal bupivacaine (Exparel, Pacira Pharmaceuticals, Parsippany NJ). Specifically, the primary aims of this study are to compare these two interventions on the following: post-operative opioid consumption, pain scores, and patient satisfaction. Additionally, the investigators want to determine if psychological factors, catastrophizing and resilience, are associated with post-operative pain control and satisfaction. The investigators' hypothesis is that the two interventions will have similar pain control efficacy and that the liposomal bupivacaine group will experience faster post-operative recovery, earlier discharge, and improved satisfaction. The investigators also expect patient catastrophizing and resilience to significantly predict the degree of post-operative pain and level of patient satisfaction.

Registry
clinicaltrials.gov
Start Date
February 5, 2019
End Date
November 1, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Adam Schumaier

Principal Investigator

University of Cincinnati

Eligibility Criteria

Inclusion Criteria

  • patients who are older than 18 years
  • patients undergoing reverse total shoulder arthroplasty

Exclusion Criteria

  • pregnancy
  • inability to provide informed consent
  • deemed unreliable for follow-up survey completion
  • individuals who do not speak English
  • those who have an allergy to the study medications (ropivicaine, bupivicaine) or have clinically significant hepatic disease

Arms & Interventions

Liposomal Bupivacaine

Patients in this group will receive a single intra-operative injection of liposomal bupivacaine near the surgical site (40 ml total: consisting of 20 ml 1.3% liposomal bupivacaine and 20 ml normal saline).

Intervention: Exparel

Interscalene Nerve Block

Patients in this group will receive a single pre-operative interscalene nerve block in the neck/shoulder consisting of 30 ml 0.5% ropivacaine.

Intervention: Interscalene Nerve Block

Outcomes

Primary Outcomes

Patient Satisfaction: Rating

Time Frame: 72 hours post-operatively

Rating of satisfaction with post-operative pain management from 0 (least satisfied) to 10 (most satisfied)

Relationship between resilience, pain, and patient satisfaction

Time Frame: Resilience will be measured pre-operatively

The effect of patient resilience (measured using the Brief Resilience Scale) on post-operative pain control and satisfaction. The Brief Resilience Scale measures how individuals psychologically respond to pain and hardship, and it ranges from a minimum score of 1 to a maximum score of 5. Higher scores on the Brief Resilience Scale indicate greater resilience. The patients' resilience scores will be correlated with their post-operative pain scores and their satisfaction scores. A correlation closer to -1 or 1 (correlations range from -1 to 1) indicates a stronger relationship between resilience with pain control and satisfaction.

Opioid Consumption

Time Frame: 72 hours post-operatively

Post-operative use of opioid pain medications, measured in morphine equivalents (higher scores are worse)

Visual Analog Scale Pain Scores

Time Frame: 72 hours post-operatively

Post-operative level of pain measured from 0 (no pain) to 10 (worst pain)

Relationship between catastrophizing, pain, and patient satisfaction

Time Frame: Catastrophizing will be measured pre-operatively

The effect of patient catastrophizing (measured using the Pain Catastrophizing Scale) on post-operative pain control and satisfaction. The Pain Catastrophizing Scale measures how individuals psychologically respond to pain and hardship, and it ranges from a minimum score of 0 to a maximum score of 52. Higher scores on the Pain Catastrophizing Scale indicate more catastrophic thinking. The patients' catastrophizing scores will be correlated with their post-operative pain scores and their satisfaction scores. A correlation closer to -1 or 1 (correlations range from -1 to 1) indicates a stronger relationship between catastrophizing with pain control and satisfaction.

Study Sites (1)

Loading locations...

Similar Trials